Lumicera Earns URAC Rare Disease Pharmacy Center of Excellence Certification, Reinforcing Commitment to Specialized Patient Care

Achievement recognizes Lumicera’s advanced capabilities serving rare-disease populations

MADISON, Wis. – March 2, 2026 – Lumicera Health Services, a leading specialty pharmacy solutions provider and Top 10 national specialty pharmacy, announced today that it has earned URAC’s Rare Disease Pharmacy Center of Excellence Certification.

This premier, evidence-based certification recognized specialty pharmacies demonstrating exceptional, high-touch care and advanced capabilities serving patients with rare and complex conditions. This designation builds on Lumicera’s existing URAC Specialty Pharmacy Accreditation, further validating Lumicera’s commitment to exceeding expectations for patients requiring specialized therapies and individualized support.

The new certification elevated recognition for pharmacies already holding a Specialty Pharmacy Accreditation and demonstrates enhanced performance standards caring for rare-disease populations. The review process for the new certification evaluates a pharmacy’s ability to provide comprehensive clinical management, coordinate care, patient education and operational excellence tailored to individuals living with rare conditions.

“Patients with rare disease often face complex treatment journeys requiring specialized clinical expertise, proactive coordination and hands-on support,” said Chelsea Hustad, Lumicera’s Clinical Services and Residency Program Director. “Earning URAC’s Rare Disease Pharmacy Center of Excellence Certification affirms the rigor of our clinical programs and the dedication of our teams ensuring that patients receive the highest levels of individualized, high-touch care.”

Rare-disease patients frequently require advanced therapies, ongoing monitoring, coordination across multiple providers and support navigating financial and access barriers. Lumicera provides personalized care plans, clinical oversight, adherence support and close collaboration with prescribers and payers to optimize outcomes.

This certification reinforces Lumicera’s broader specialty pharmacy strategy and commitment to advancing care for patients with complex and rare conditions. As demand grows for specialty and rare-disease therapies, Lumicera delivers clinically sounds, patient-focused services that balance access, safety and sustainability.

About Lumicera Health Services

Lumicera Health Services, a leading specialty pharmacy solutions provider, is a wholly owned subsidiary of Navitus Health Solutions, which is owned by SSM Health and Costco Wholesale Corp. Founded in 2014, Lumicera improves specialty care, one patient at a time, through educational, clinical, financial and service excellence. Lumicera brings clinicians closer to patients and drives positive outcomes through innovative practices and strategic partnerships. For more information, please visit www.lumicera.com.

For questions and media inquiries, please email [email protected].